DelveInsight has added a new research study on Atopic Dermatitis Market Report with detailed information on the overview, market insights, drugs industry, treatment, growth, size, share, trends, during the forecast period of 2017 to 2030
Atopic Dermatitis Overview
Atopic dermatitis (AD), also known as atopic eczema, is a type of inflammation of the skin (dermatitis). It results in itchy, red, swollen, and cracked skin. Clear fluid may come from the affected areas, which often thickens over time. While the condition may occur at any age, it typically starts in childhood with changing severity over the years.
Download Full PDF Sample copy of Atopic Dermatitis Market Report @ https://www.delveinsight.com/sample-request/atopic-dermatitis-ad-market
Atopic Dermatitis Market: Regions Covered
List of Companies involved in Atopic Dermatitis Market Report are:-
Atopic Dermatitis Symptoms
The cause is unknown but believed to involve genetics, immune system dysfunction, environmental exposures, and difficulties with the permeability of the skin. If one identical twin is affected, there is an 85% chance the other also has the condition. Those who live in cities and dry climates are more commonly affected. Exposure to certain chemicals or frequent hand washing makes symptoms worse. While emotional stress may make the symptoms worse. The disorder is not contagious. The diagnosis is typically based on the signs and symptoms.
Atopic Dermatitis Causes
Atopic eczema causes the skin to become itchy, dry, cracked and sore. Some people only have small patches of dry skin, but others may experience widespread inflamed skin all over the body. Inflamed skin can become red on lighter skin, and darker brown, purple or grey on darker skin. This can also be more difficult to see on darker skin. People with atopic eczema usually have periods when symptoms are less noticeable, as well as periods when symptoms become more severe (flare-ups).
Atopic Dermatitis Treatment
Currently, there is no cure for AD; however, it can be effectively managed with current treatment options. The pattern of the disease and its severity determine the kind of treatment the patient ought to receive. Treatment options include topical treatments like emollients, topical corticosteroids (TCS), antibiotics, topical calcineurin inhibitors (TCIs), and systemic treatment such as immunosuppressant, corticosteroids, and phototherapy. Drugs such as Eucrisa (Crisaborole), Dupixent (Dupilumab), Corectim ointment and Olumiant (baricitinib) are approved for AD.
Atopic Dermatitis Market Insights
When AD is mild, dermatologists may begin treatment by asking patients to avoid known triggers and to moisturize regularly to protect and strengthen the skin barrier. The maintenance therapy for AD consists of the liberal use of emollients and daily bathing practice with soap-free cleansers.
Atopic Dermatitis Market Forecast
The current US market for AD is dominated by several topical treatment options such as emollients, topical corticosteroids (TCS) +antibiotics, topical calcineurin inhibitors (TCIs), Eucrisa ointment and systemic treatment such as immunosuppressant, corticosteroids, Dupixent and others (phototherapy).
Atopic Dermatitis: Expected Launch of Therapies
Abrocitinib (PF-04965842), FB-401, Difamilast (OPA-15406) and ARQ-151 (Roflumilast cream), Rinvoq (ABR-494), Lebrikizumab (LY3650150), Etrasimod (APD334), FB825, Nemolizumab (CD14152), Tralokinumab ± TCS, DS107, Bermekimab, KY1005, Q301 (zileuton) and Ruxolitinib cream, may increase market size in the coming years, assisted by an increase in prevalent population of AD.
Read Detailed Table of content of Atopic Dermatitis Market Report
1. Key Insights
2. Executive Summary of Atopic Dermatitis
3. Competitive Intelligence Analysis for Atopic Dermatitis
4. Atopic Dermatitis: Market Overview at a Glance
5. Atopic Dermatitis: Disease Background and Overview
6. Patient Journey
7. Atopic Dermatitis Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Atopic Dermatitis Treatment
11. Marketed Products
12. Emerging Therapies
13. Atopic Dermatitis: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Atopic Dermatitis
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Key Questions Answered in the Atopic Dermatitis Market report-
How Does This Atopic Dermatitis Market Insights Help?
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Media ContactCompany Name: DelveInsight Business ResearchContact Person: Yash BhardwajEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/